Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IOngoingD-0388-2026

Drug recall · March 11, 2026

SILINTAN 25/pills recall

Why: Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam.

Class I: a reasonable chance the product could cause serious harm or death.

The recall

Product

SILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works, Shanghai, China

Lots / codes

All lots within expiry

Quantity
N/A
Company
ANTHONY TRINH, 123Herbals LLC, Rosemead, CA
Distribution
USA nationwide
Initiated
October 20, 2025 · Voluntary: Firm initiated
Classified
March 13, 2026
Reported
March 11, 2026
How notified
Press Release

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.